Count Down to relaunch

GSK Egypt considers merger with Amoun

GSK Egypt considers merger with Amoun

ArabFinance: GlaxoSmithKline (GSK) Egypt mulls merger with its subsidiary Amoun Pharmaceutical Company, according to a disclosure.

The company's board members gave a green light on December 23rd to form a committee to decide on the matter.

The committee will study the legal, financial, and structural aspects of the transaction.

Earlier this month, GSK Egypt earlier denied news circulated on the potential takeover of Amoun.

Saudi Arabia’s Public Investment Fund and UAE-based ADQ were reportedly considering the acquisition of Amoun, but no deals were sealed yet.


#Related keywords


Recommended Stocks

11 Oct 2020
Tenth Of Ramadan Pharmaceutica... RMDA

All rights reserved to Arab Finance 2020 ©

Back to top